[On the relation between steroids and carcinogenic compounds (V). 2-Acetamino- and 3-acetamino-delta 1.3.5.(10) estratrienol-(17beta)].
D000236:Adenoma / Q000139:chemically induced; D000818:Animals; D002273:Carcinogens; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced; D004958:Estradiol; D005260:Female; D005989:Glycerides; D006390:Hemangioendothelioma / Q000139:chemically induced; D007279:Injections, Subcutaneous; D007680:Kidney Neoplasms / Q000139:chemically induced; D007945:Leukemia, Lymphoid / Q000139:chemically induced; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced; D051379:Mice; D009369:Neoplasms / Q000139:chemically induced*; D012509:Sarcoma / Q000139:chemically induced; D013160:Splenic Neoplasms / Q000139:chemically induced; D013535:Suspensions
D002273:Carcinogens; D005989:Glycerides; D013535:Suspensions; D004958:Estradiol
Uber Beziehungen zwischen Steroiden und krebserzeugenden Verbindungen (V.) 2-Acetamino- und 3-Acetamino-delta 1.3.5.(10) oestratrien sowie 3-Amino-delta 1.3.5.(10) oestratrienol-(17beta)